Seaport Therapeutics, Inc. Common Stock
NASDAQ:SPTXBiotechnology
Healthcare
$18.31 +0.58%
+$0.10 today
- Market cap
- $980.14M
- Beta
- 0.00
52W Low $14.85High $23.00
Volume 0.68M
Average 0.41M
SPTX Total Non-current Liabilities
All obligations due after more than one year.
No reported Total Non-current Liabilities figures are available to summarize.
Total Non-current Liabilities history
Currency unavailable · from the balance sheet
No Total Non-current Liabilities data reported for this period type.
Total Non-current Liabilities vs competitors
How SPTX compares with its peers on the latest reported figures
SPTX Competitors
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
NMRANeumora Therapeutics, Inc. Common Stock | Mar 2026 | $53.08M USD | — | -59.9% | 34.5% |
| Mar 2026 | $17.18M USD | +3.5% | +2.1% | 4.0% | |
RAPPRapport Therapeutics, Inc. Common Stock | Mar 2026 | $8.19M USD | +19.8% | -5.8% | 1.6% |
| Mar 2026 | $4.67M USD | -16.4% | -6.1% | 1.1% | |
CTNMContineum Therapeutics, Inc. Class A Common Stock | Mar 2026 | $4.65M USD | +2.3% | +15.7% | 1.8% |
LBRXLB Pharmaceuticals Inc Common Stock | Mar 2026 | $3.88M USD | -21.7% | -56.2% | 1.0% |
| Mar 2026 | $75K USD | -76.7% | -57.1% | 0.0% | |
SPTXSeaport Therapeutics, Inc. Common Stock | — | — | — | — | — |
| Peer median (excluding SPTX) | — | -7.1% | -6.1% | 1.6% | |
Competitors are the stored peer set for SPTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Currency unavailable
Seaport Therapeutics, Inc. Common Stock
NASDAQ:SPTX
Intrinsic Alpha fair value
Locked
Current Price
$18.31
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.